Ethzilla Corporation (ETHZ)

$2.47 +0.03 (1.23%)
Market Cap 14.74M
Revenue (ttm) 0.00
Net Income (ttm) -6.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 9,747,200
Avg Vol 15,752,548
Day's Range N/A - N/A
Shares Out 6.04M
Stochastic %K 36%
Beta 0.37
Analysts Strong Buy
Price Target $4.00

Company Profile

ETHZilla Corporation, a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which a...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 507 0669
Address:
2875 South Ocean Blvd, Suite 200, Palm Beach, United States
InvestForDaKids
InvestForDaKids Sep. 11 at 3:03 AM
$ETHZ lets go $22
1 · Reply
spusulri
spusulri Sep. 11 at 3:00 AM
$ETHZ I’m slightly late to the game but I just saw this on moomoo news: “On September 5, 2025, amended its Asset Management Agreement with Electric Treasury Edge, LLC, expanding the scope of account assets and advisory services. Additionally, on September 8, 2025, ETHZilla’s subsidiary entered into a Transaction Agreement with Cumberland DRW LLC to secure up to $80 million, collateralized by $125 million in ETH, to fund its $250 million program. The company has repurchased 2.2 million shares, reducing outstanding shares by 1.3%, and appointed McAndrew Rudisill as CEO. ETHZilla’s current ETH holdings are valued at $443 million, with $213 million in USD cash equivalents.”
0 · Reply
gradeAsetup
gradeAsetup Sep. 11 at 1:38 AM
$BMNR this and $ETHZ were pretty much tandem with $ETHX.X movements today. Make sense that the market would get excited over PPI days and then sell off in anticipation of CPI tomorrow. It pays to have a game plan ahead of time.
0 · Reply
caseypc
caseypc Sep. 11 at 12:39 AM
$ETHZ I still believe in you
0 · Reply
AutoAZTrader
AutoAZTrader Sep. 11 at 12:02 AM
$ETHZ FUCKING JOKE. AT LEAST IT DIDN'T GO RED.
0 · Reply
ikan300
ikan300 Sep. 10 at 11:46 PM
$OCTO $ETHZ $NVDA DVLT DVLT DVLT great technology for 30 cents a share nasdaq listed company https://www.youtube.com/watch?v=JHsDN6e_Ha8
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 10 at 11:41 PM
Enter: $ETHZ OCT 17 2025 $2 CALLS Buy in Price: $0.38 - $0.40 Take Profit: $0.44 Stop Bleeding: $0.33 ROI Potential: 15% Exit Within: 21 Minutes https://moneygroup.us/alerts
0 · Reply
Wukong13
Wukong13 Sep. 10 at 10:50 PM
$ETHZ missed out on so many plays. Keep waiting. Might get $3 🥴
0 · Reply
lifeonthewater
lifeonthewater Sep. 10 at 10:33 PM
$ETHZ This baby will FLY after Sep 17th Paytience Mark it
0 · Reply
Jaws222
Jaws222 Sep. 10 at 9:36 PM
$ETHZ
1 · Reply
Latest News on ETHZ
ETHZilla Announces ETH Accumulation and Leadership Updates

Sep 8, 2025, 8:15 AM EDT - 2 days ago

ETHZilla Announces ETH Accumulation and Leadership Updates

ETHZilla Plans to Deploy $100 Million in ETH to EtherFi for Restaking Initiatives

Sep 2, 2025, 8:00 AM EDT - 8 days ago

ETHZilla Plans to Deploy $100 Million in ETH to EtherFi for Restaking Initiatives

Bitcoin erases summer gains, crypto treasury stocks fall in August

Aug 29, 2025, 7:23 PM EDT - 12 days ago

Bitcoin erases summer gains, crypto treasury stocks fall in August

BMNR MSTR SBET

New Ether Treasury ETHZilla Stock Jumps on Buyback Program

Aug 25, 2025, 10:50 AM EDT - 16 days ago

New Ether Treasury ETHZilla Stock Jumps on Buyback Program

ETHZilla announces authorization of $250 million stock repurchase program

Aug 25, 2025, 8:00 AM EDT - 16 days ago

ETHZilla announces authorization of $250 million stock repurchase program

Crypto Treasury stocks see pullback in August

Aug 20, 2025, 5:31 PM EDT - 21 days ago

Crypto Treasury stocks see pullback in August

BMNR BNC MSTR

ETHZilla Unveils New Brand Committed to Advancing Ethereum Treasury Strategy

Aug 18, 2025, 8:00 AM EDT - 23 days ago

ETHZilla Unveils New Brand Committed to Advancing Ethereum Treasury Strategy

Stock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus

Aug 15, 2025, 5:55 AM EDT - 26 days ago

Stock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus

INTC IVV SPLG SPXL SPY SSO UNH

180 Life Sciences (ETHZilla) Holds 82,186 ETH

Aug 12, 2025, 8:00 AM EDT - 4 weeks ago

180 Life Sciences (ETHZilla) Holds 82,186 ETH

180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes

Aug 11, 2025, 8:00 AM EDT - 4 weeks ago

180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes

180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy

Aug 4, 2025, 10:30 PM EDT - 5 weeks ago

180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy

180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla

Jul 29, 2025, 9:26 AM EDT - 6 weeks ago

180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla

180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets

Jul 1, 2025, 7:30 AM EDT - 2 months ago

180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets

180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction

May 1, 2025, 9:30 AM EDT - 4 months ago

180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction

180 Life Sciences Corp. Announces Share Repurchase

Apr 30, 2025, 8:30 AM EDT - 4 months ago

180 Life Sciences Corp. Announces Share Repurchase

180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules

Dec 27, 2024, 9:00 AM EST - 9 months ago

180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules

180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

Dec 12, 2024, 8:00 AM EST - 9 months ago

180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

Dec 4, 2024, 8:00 AM EST - 10 months ago

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

Oct 31, 2024, 8:00 AM EDT - 11 months ago

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

Oct 29, 2024, 8:00 AM EDT - 11 months ago

180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

This biotech stock soared a whopping 900% on Wednesday: here's why

Oct 16, 2024, 4:03 PM EDT - 11 months ago

This biotech stock soared a whopping 900% on Wednesday: here's why

180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform

Oct 16, 2024, 8:00 AM EDT - 11 months ago

180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector

Oct 9, 2024, 8:30 AM EDT - 1 year ago

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector

180 Life Sciences Corp. - Corporate Updates

Oct 3, 2024, 8:30 AM EDT - 1 year ago

180 Life Sciences Corp. - Corporate Updates

180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer

Sep 12, 2024, 4:15 PM EDT - 1 year ago

180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer

180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake

Jul 30, 2024, 8:00 AM EDT - 1 year ago

180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake

180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

Jul 2, 2024, 8:30 AM EDT - 1 year ago

180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

Mar 14, 2024, 8:30 AM EDT - 1 year ago

180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan

Feb 26, 2024, 7:00 AM EST - 1 year ago

180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan

180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives

Dec 4, 2023, 9:00 AM EST - 1 year ago

180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives

180 Life Sciences Announces Review of Strategic Alternatives

Nov 28, 2023, 9:00 AM EST - 1 year ago

180 Life Sciences Announces Review of Strategic Alternatives

180 Life Sciences Corp. Announces Closing of $3 Million Public Offering

Aug 14, 2023, 4:29 PM EDT - 2 years ago

180 Life Sciences Corp. Announces Closing of $3 Million Public Offering

180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering

Aug 10, 2023, 8:46 AM EDT - 2 years ago

180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering

180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake

Aug 7, 2023, 9:00 AM EDT - 2 years ago

180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake

180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private Placement

Apr 10, 2023, 4:30 PM EDT - 2 years ago

180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private Placement

180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placement

Apr 5, 2023, 1:00 PM EDT - 2 years ago

180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placement

180 Life Sciences Announces Presentation at the Gordon Conference

Feb 27, 2023, 8:30 AM EST - 2 years ago

180 Life Sciences Announces Presentation at the Gordon Conference

180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren's Disease Treatment and Application

Feb 23, 2023, 7:30 AM EST - 2 years ago

180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren's Disease Treatment and Application

180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder Trial

Feb 22, 2023, 4:30 PM EST - 2 years ago

180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder Trial

180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren's Disease

Jan 25, 2023, 8:45 AM EST - 2 years ago

180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren's Disease

Newman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)

Jan 10, 2023, 1:56 PM EST - 2 years ago

Newman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)

180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren's Disease

Jan 4, 2023, 8:30 AM EST - 2 years ago

180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren's Disease

180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders

Dec 29, 2022, 8:30 AM EST - 2 years ago

180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders

180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Dec 23, 2022, 8:00 AM EST - 2 years ago

180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Dec 20, 2022, 2:11 PM EST - 2 years ago

180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

180 Life Sciences Corp. Announces 1-for 20 Reverse Stock Split as Part of Nasdaq Compliance Plan

Dec 16, 2022, 9:00 AM EST - 2 years ago

180 Life Sciences Corp. Announces 1-for 20 Reverse Stock Split as Part of Nasdaq Compliance Plan

180 Life Sciences Provides Update on Progress To Seek Medicines and Healthcare Products Regulatory Agency Marketing Authorization for Anti-TNF Treatment of Early Stage Dupuytren's Contracture

Nov 30, 2022, 5:00 PM EST - 3 years ago

180 Life Sciences Provides Update on Progress To Seek Medicines and Healthcare Products Regulatory Agency Marketing Authorization for Anti-TNF Treatment of Early Stage Dupuytren's Contracture

180 Life Sciences to Participate in A.G.P.'s Virtual Biotech Conference to be Held November 30 – December 1, 2022

Nov 21, 2022, 8:30 AM EST - 3 years ago

180 Life Sciences to Participate in A.G.P.'s Virtual Biotech Conference to be Held November 30 – December 1, 2022

CORRECTION: Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytren's Disease

Nov 15, 2022, 12:37 PM EST - 3 years ago

CORRECTION: Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytren's Disease

180 Life Sciences Issues Letter to Stockholders

Sep 26, 2022, 8:30 AM EDT - 3 years ago

180 Life Sciences Issues Letter to Stockholders

InvestForDaKids
InvestForDaKids Sep. 11 at 3:03 AM
$ETHZ lets go $22
1 · Reply
spusulri
spusulri Sep. 11 at 3:00 AM
$ETHZ I’m slightly late to the game but I just saw this on moomoo news: “On September 5, 2025, amended its Asset Management Agreement with Electric Treasury Edge, LLC, expanding the scope of account assets and advisory services. Additionally, on September 8, 2025, ETHZilla’s subsidiary entered into a Transaction Agreement with Cumberland DRW LLC to secure up to $80 million, collateralized by $125 million in ETH, to fund its $250 million program. The company has repurchased 2.2 million shares, reducing outstanding shares by 1.3%, and appointed McAndrew Rudisill as CEO. ETHZilla’s current ETH holdings are valued at $443 million, with $213 million in USD cash equivalents.”
0 · Reply
gradeAsetup
gradeAsetup Sep. 11 at 1:38 AM
$BMNR this and $ETHZ were pretty much tandem with $ETHX.X movements today. Make sense that the market would get excited over PPI days and then sell off in anticipation of CPI tomorrow. It pays to have a game plan ahead of time.
0 · Reply
caseypc
caseypc Sep. 11 at 12:39 AM
$ETHZ I still believe in you
0 · Reply
AutoAZTrader
AutoAZTrader Sep. 11 at 12:02 AM
$ETHZ FUCKING JOKE. AT LEAST IT DIDN'T GO RED.
0 · Reply
ikan300
ikan300 Sep. 10 at 11:46 PM
$OCTO $ETHZ $NVDA DVLT DVLT DVLT great technology for 30 cents a share nasdaq listed company https://www.youtube.com/watch?v=JHsDN6e_Ha8
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 10 at 11:41 PM
Enter: $ETHZ OCT 17 2025 $2 CALLS Buy in Price: $0.38 - $0.40 Take Profit: $0.44 Stop Bleeding: $0.33 ROI Potential: 15% Exit Within: 21 Minutes https://moneygroup.us/alerts
0 · Reply
Wukong13
Wukong13 Sep. 10 at 10:50 PM
$ETHZ missed out on so many plays. Keep waiting. Might get $3 🥴
0 · Reply
lifeonthewater
lifeonthewater Sep. 10 at 10:33 PM
$ETHZ This baby will FLY after Sep 17th Paytience Mark it
0 · Reply
Jaws222
Jaws222 Sep. 10 at 9:36 PM
$ETHZ
1 · Reply
tErRiBle_TrAdEr
tErRiBle_TrAdEr Sep. 10 at 9:32 PM
$ETHZ permabulls stop being delusional
0 · Reply
pmb0928
pmb0928 Sep. 10 at 8:32 PM
$ETHZ This is so undervalued, have patience everyone, great spot to accumulate still.
0 · Reply
InvestForDaKids
InvestForDaKids Sep. 10 at 8:19 PM
$ETHZ lets go $6.8
0 · Reply
BullsEye2000
BullsEye2000 Sep. 10 at 8:15 PM
$ETHZ patience folks. This’ll rip just like ASST and KIDZ did.
2 · Reply
dukesar
dukesar Sep. 10 at 8:11 PM
$ETHZ so are they buying below 2.5 and selling above that's their tactic?
2 · Reply
Jaws222
Jaws222 Sep. 10 at 8:05 PM
$ETHZ Now down 44%
1 · Reply
AutoAZTrader
AutoAZTrader Sep. 10 at 8:04 PM
$ETHZ Hey, green is green; this is the greenest day in two weeks. Yes, it's a piece of shit, but I think we've found a bottom.
0 · Reply
Jaws222
Jaws222 Sep. 10 at 8:00 PM
$ETHZ another lackluster day
0 · Reply
Wukong13
Wukong13 Sep. 10 at 7:35 PM
$ETHZ when is it my turn? $KIDZ
0 · Reply
Wirralboy
Wirralboy Sep. 10 at 7:23 PM
$ETHZ weekly chart looks good with steady increase in price all week
0 · Reply
Jaws222
Jaws222 Sep. 10 at 7:21 PM
$ETHZ Bet it finishes where it started today
1 · Reply
Jaws222
Jaws222 Sep. 10 at 7:20 PM
$ETHZ Not even trying to disguise the dilution
0 · Reply